Artikelen

Dasatinib - post-filing data in Europe (pdf)

Dec 20, 2016 | Tags: Octrooien

Has the EPO's Enlarged Board detoxified "Poisonous Divisionals"? (pdf)

Dec 20, 2016 | Tags: Octrooien

UK IP Office Opinions - A Low Key Route to Challenging Validity (pdf)

Dec 20, 2016 | Tags: Octrooien

EPO Enlarged Board Referral on Disclaimers and Added Matter G1/16 (pdf)

Dec 20, 2016 | Tags: Octrooien

Brexit Update (pdf)

Dec 15, 2016 | Tags: Octrooien

10 Things to Know About Supplementary Protection Certificates in Europe (pdf)

Dec 15, 2016 | Tags: Octrooien

G1/15 Newsflash - Has the EPO Detoxified Poisonous Divisionals? (pdf)

Dec 2, 2016 | Tags: Octrooien

EP0 Enlarged Board Referral on Disclaimers (pdf)

Dec 1, 2016 | Tags: Octrooien

The Unitary Patent Package is back on the table. (pdf)

Nov 29, 2016 | Tags: Octrooien

"Brexit" Update (pdf)

Nov 11, 2016 | Tags: Octrooien , Merken , Modellen

The Patent Box Repackaged Briefing Note (pdf)

Oct 20, 2016 | Tags: Octrooien

The UK IPO Opinions Briefing Note (pdf)

Oct 13, 2016 | Tags: Octrooien

Guide To The Unitary Patent and Unified Patent Court - April 2016 (pdf)

Aug 3, 2016 | Tags: Octrooien

Brexit - Chinese Edition (pdf)

Jul 11, 2016 | Tags: Octrooien , Merken

Brexit Effect on Trade Marks & Designs (pdf)

Jun 29, 2016 | Tags: Merken , Modellen

EU Trade Mark Reform - Class Headings (pdf)

Jun 29, 2016 | Tags: Merken